Xiaoqiang Xiang

3.4k total citations · 1 hit paper
106 papers, 2.5k citations indexed

About

Xiaoqiang Xiang is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Xiaoqiang Xiang has authored 106 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 35 papers in Pharmacology and 29 papers in Oncology. Recurrent topics in Xiaoqiang Xiang's work include Pharmacogenetics and Drug Metabolism (27 papers), Drug Transport and Resistance Mechanisms (20 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Xiaoqiang Xiang is often cited by papers focused on Pharmacogenetics and Drug Metabolism (27 papers), Drug Transport and Resistance Mechanisms (20 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Xiaoqiang Xiang collaborates with scholars based in China, Singapore and United States. Xiaoqiang Xiang's co-authors include Lingzhi Wang, Boon Cher Goh, Zhaowu Ma, Weimin Cai, Andrea Li‐Ann Wong, Pei Shi Ong, Ling‐Wen Ding, Paul C. Ho, Boon-Cher Goh and Gautam Sethi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Xiaoqiang Xiang

97 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol for cancer therapy: Challenges and future perspectives

2021 334 citations Zhaowu Ma, Ling‐Wen Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoqiang Xiang China	28	946	590	416	334	329	106	2.5k
Guoyu Pan China	29	1.1k 1.1×	649 1.1×	128 0.3×	506 1.5×	277 0.8×	87	3.0k
Shu Zhou China	27	1.1k 1.1×	505 0.9×	295 0.7×	377 1.1×	384 1.2×	86	2.8k
Lu Fan Singapore	23	1.2k 1.3×	526 0.9×	330 0.8×	442 1.3×	113 0.3×	39	2.4k
Khalid Saad Alharbi Saudi Arabia	29	1.0k 1.1×	226 0.4×	277 0.7×	170 0.5×	327 1.0×	141	2.7k
Ming Yao United States	23	936 1.0×	544 0.9×	380 0.9×	317 0.9×	87 0.3×	68	2.3k
Xian Zeng China	30	1.5k 1.6×	215 0.4×	230 0.6×	175 0.5×	196 0.6×	99	3.0k
Daping Fan United States	44	2.2k 2.3×	486 0.8×	957 2.3×	190 0.6×	159 0.5×	137	5.0k
Young‐Jin Chun South Korea	28	1.2k 1.3×	557 0.9×	336 0.8×	970 2.9×	84 0.3×	98	2.7k
Sandra Lindstedt Sweden	33	1.3k 1.4×	241 0.4×	220 0.5×	136 0.4×	553 1.7×	222	4.8k
Fang Zhou China	29	1.1k 1.1×	444 0.8×	269 0.6×	398 1.2×	211 0.6×	94	2.1k

Countries citing papers authored by Xiaoqiang Xiang

Since Specialization

Citations

This map shows the geographic impact of Xiaoqiang Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqiang Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqiang Xiang more than expected).

Fields of papers citing papers by Xiaoqiang Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqiang Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqiang Xiang. The network helps show where Xiaoqiang Xiang may publish in the future.

Co-authorship network of co-authors of Xiaoqiang Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqiang Xiang. A scholar is included among the top collaborators of Xiaoqiang Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqiang Xiang. Xiaoqiang Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Weijian, Wei Li, Wen Yao Mak, et al.. (2025). Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection. Journal of Antimicrobial Chemotherapy. 80(4). 1022–1030.

Shi, Xiao‐Ping, Qing Xu, Xiaoyu Li, et al.. (2025). Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipients. Journal of Antimicrobial Chemotherapy. 80(7). 1915–1925.

Guo, Nan, et al.. (2025). Cost–utility analysis of sotagliflozin for heart failure patients with diabetes in China. British Journal of Clinical Pharmacology. 1 indexed citations

Mak, Wen Yao, et al.. (2025). PBPK Modeling: Empowering Drug Development and Precision Dosing in China. CPT Pharmacometrics & Systems Pharmacology. 14(5). 828–839. 1 indexed citations

He, Qingfeng, Min Li, Yao Li, et al.. (2024). Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach. Toxicology and Applied Pharmacology. 491. 117064–117064. 2 indexed citations

Wang, Kun, et al.. (2024). Pharmacokinetics and exposure–safety relationship of ciprofol for sedation in mechanically ventilated patients in the intensive care unit. CPT Pharmacometrics & Systems Pharmacology. 13(5). 823–836. 4 indexed citations

Wu, Dan, Jiang Pin, Qingfeng He, et al.. (2024). Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive Study. Journal of Pharmaceutical Sciences. 113(9). 2861–2870. 2 indexed citations

Mak, Wen Yao, Yue Wu, Qingfeng He, et al.. (2024). Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics. 16(6). 819–819. 1 indexed citations

Yap, Chun Wei, et al.. (2023). Prediction of drug permeation through microneedled skin by machine learning. Bioengineering & Translational Medicine. 8(6). e10512–e10512. 20 indexed citations

10.

Ji, Xiwei, et al.. (2023). Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International Journal of Molecular Sciences. 24(1). 757–757. 2 indexed citations

11.

Li, Zhihong, Ke Wang, Qingfeng He, et al.. (2023). Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules. 28(2). 837–837. 1 indexed citations

12.

Wang, Xiaowen, Fang Chen, Nan Guo, et al.. (2023). Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs. Cancer Chemotherapy and Pharmacology. 92(4). 253–270. 7 indexed citations

13.

Ding, Ling‐Wen, Henry Yang, Jonathan W. Said, et al.. (2023). Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer Research. 83(6). 922–938. 12 indexed citations

14.

He, Qingfeng, et al.. (2022). Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules. 27(24). 8670–8670. 6 indexed citations

15.

Harjumäki, Riina, et al.. (2021). Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible Three-Dimensional Cell Culture Systems: Possibilities and Limitations. Frontiers in Cell and Developmental Biology. 9. 726499–726499. 8 indexed citations

16.

Cai, Weimin, et al.. (2020). Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: A physiologically based pharmacokinetic/pharmacodynamic analysis. British Journal of Clinical Pharmacology. 87(7). 2790–2806. 11 indexed citations

17.

Ma, Zhaowu, Jun-Ting Cheng, Sze Tung Lam, et al.. (2020). Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy. Antioxidants and Redox Signaling. 34(18). 1484–1497. 78 indexed citations

18.

Liu, Hongrui, et al.. (2019). A Sensitive HPLC-MS/MS Method for the Quantification of Selegiline in Beagle Dog Plasma: Application to a Pharmacokinetic Study. Current Pharmaceutical Analysis. 17(1). 140–148. 1 indexed citations

19.

Wang, Kun, Xiaoqiang Xiang, Jiang Liu, et al.. (2018). The value and general consideration of pharmacometric study in new drug development. Zhongguo linchuang yaolixue yu zhiliaoxue. 23(9). 961. 3 indexed citations

20.

Wong, Andrea L.A., Xiaoqiang Xiang, Pei Shi Ong, et al.. (2018). A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs. Preprints.org. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact